Dosage and formulation
US9254262B2 · kind B2 · utility
6Cited by
73References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 9, 2012 |
| Grant date | Feb 9, 2016 |
| Priority date | — |
| Expiry date | Nov 9, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to pharmaceutical compositions for inhalation comprising aclidinium in the form of a dry powder of a pharmaceutically acceptable salt in admixture with a pharmaceutically acceptable dry powder carrier, providing a metered nominal dose of aclidinium equivalent to about 200 micrograms aclidinium bromide.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.